Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner xarelto lawsuit claims (rivaroxaban) and suffered serious bleeding events. Pharmaceutical organizations, which includes the makers of Xarelto, have a duty to ensure that their drugs are reasonably protected for use - and failure to do so may possibly be grounds for compensation. Our lawyers are functioning difficult to have these hurt by the drug the compensation they're entitled to.













image class="left" url="https://images51.fotki.com/v1654/photos/2/3651632/13703394/Xareltolawyer020615-vi.jpg"Whilst bleeding is actually a typical complication associated with anticoagulants, it has been alleged that Xarelto is far more dangerous than classic blood thinners simply because no antidote exists to reverse its blood-thinning effects. This indicates that, in the occasion of an emergency, patients might be at danger for irreversible bleeding difficulties, which includes life-threatening internal and gastrointestinal hemorrhaging.













Should you or possibly a loved 1 suffered a serious bleeding event soon after taking Xarelto, you may have legal recourse. For far more information, make contact with us these days to have your case reviewed, free of charge of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for past and future healthcare bills, lost wages, pain and suffering and, in situations of death, funeral expenses. Moreover, they're in search of punitive damages, that are typically awarded to punish the defendant and deter other organizations from acting similarly.






Why Are Lawsuits Getting Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs in the lawsuits allege significant and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a secure anticoagulant option.






Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.






Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.













Visit this page for more details on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













image class="left" url="https://images59.fotki.com/v544/photos/2/3651632/13703394/Xareltolawsuit190515-vi.jpg"The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki